NewsSource: EClinCloud

Meet EClinCloud in Shanghai, May 13–16, at the 2026 DIA China Annual Meeting!

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud. Author: EClinCloud.

Article illustration

From May 13 to 16, the 2026 DIA Drug Information Annual Meeting & Exhibition will be held at Zhangjiang Science Hall in Shanghai. Centered on the theme "Igniting Innovative Value in Regulation, R&D, and Global Access," leading life sciences professionals from more than 30 countries and regions worldwide will gather in Shanghai to connect and advance the full global biopharmaceutical value chain.


As an AI technology company focused on digital and intelligent clinical research, EClinCloud will present its full product suite and invites you to visit us to exchange ideas and explore pain points and solutions for AI-enabled transformation in clinical research.



EClinCloud DIA Booth

· Exhibition Dates: May 14–May 16

· Booth Number: Zhangjiang Science Hall, Shanghai · L23

Article illustration

Announcement and news-style WeChat Official Account dual-cover header image AIGC(2) (4).pngCheck In at the EClinCloud Booth

We have prepared gifts for you

Participate in interactive activities to enter the prize draw


Article illustration
(Image is AI-generated; actual items may vary)

Practical cable organizer pouch

Trendy robot charm

Cute luggage tag, and more



Concurrent EClinCloud User Conference

Don't Miss Out

EClinCloud 2026 User Conference

· Time: May 13, 15:00–21:00

· Location: Pudong, Shanghai (Detailed address will be sent via SMS upon registration confirmation)

From data to evidence, and from efficiency to value. Under the theme "AI-Led · A New Chapter Begins," this conference brings together founders and CEOs from well-known pharmaceutical and biotech companies, seasoned clinical research experts, and AI leaders from major technology firms to showcase cutting-edge AI practices in clinical research and open a new chapter with industry partners.


Click the image below for details

Article illustration

On-site tech gifts await you!

Article illustration


QR code (2.png

Scan the QR code to register now

Registration is subject to review and approval

(Please be sure to provide your work email address)

























Attendance Memo




5/13

● EClinCloud 2026 User Conference

Pudong, Shanghai (Detailed address provided upon registration)




5/14

5/15

5/16

● 2026 DIA China Annual Meeting Exhibition

Zhangjiang Science Hall, Shanghai, L23








About EClinCloud


EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated intelligent clinical cloud platform and endpoint assessment technologies to provide global pharmaceutical companies and research institutions with technology products—including eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM—as well as scale management, linguistic validation, rater training, and data quality analysis services, creating efficient and precise digital solutions and leveraging AI prediction models and an intelligent data platform to dynamically assess and help improve the success rate of drug clinical trials, helping shorten drug and medical device R&D timelines to benefit patients.







Article illustration



















Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.